FDA Inspection 1232706 — CSL Plasma Inc.
The FDA completed an inspection of CSL Plasma Inc. on Mar 21, 2024 in Melrose Park, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 21, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Melrose Park, IL (United States)